Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
02/2007
02/21/2007EP1355905B1 Pyrazole compounds useful as protein kinase inhibitors
02/21/2007EP1328254B1 Lipid formulations for target delivery
02/21/2007EP1255749B1 Tyrosine derivatives with anti-leukotriene activity
02/21/2007EP1224155B1 Novel bicyclic cannabinoid agonists for the cannabinoid receptor
02/21/2007EP0815202B1 Human tissue inhibitor of metalloproteinase-4
02/21/2007CN1918175A Oligonucleotide compositions and methods for treating disease including inflammatory conditions
02/21/2007CN1918159A Prodrugs of substituted amino heterobicycles which modulate the function of the vanilloid-1 receptor (vr1)
02/21/2007CN1918156A Isothiazole dioxides as cxc- and cc-chemokine receptor ligands
02/21/2007CN1918133A Alpha-4 integrin mediated cell adhesion inhibitors for the treatment or prevention of inflammatory diseases
02/21/2007CN1918118A Thioamide compound or its salt and cytokine production inhibitor containing the same
02/21/2007CN1917884A External preparation for treating painful skin wound
02/21/2007CN1916013A Pharmaceutical compounds
02/21/2007CN1915407A Medicated wine
02/21/2007CN1915403A Medication of medical broth for treating disease of wean summer fever in type of deficiency of the lung and kidney, and preparation method
02/21/2007CN1915375A Chinese traditional medicine for expeling wind and cold, relaxing muscles and tendons, harmonizing link and alleviating pain, and method for fabricating dog skin plaster purpose made
02/21/2007CN1915315A Enteric-coated prepartioon of compound rhizome of Sichuan lovage (notoperygium root) and Indomethacin, and preparation
02/21/2007CN1915310A Medication for treating disease of proplapse of lumbar intervertebral disc
02/21/2007CN1915236A Application of woodruff glycoside in preparing medication for treating rheumatoid arthritis
02/21/2007CN1915235A Application of woodruff acid with acetyl being removed in preparing medicine for treating rheumatoid arthritis
02/21/2007CN1915231A Use of nonsteroidal in preparing drug of antiinflammatory agents
02/21/2007CN1301261C Diphospho-acid complex of radiative technetium-99m marked oxazole phosphinic acid and preparation method thereof
02/21/2007CN1301255C Inhibitors of alpha l beta 2 integrin mediated cell adhesion
02/21/2007CN1301129C Medication for treating arthralgia due to wind-cold dampness and weary muscles and bones
02/21/2007CN1301122C Bone strengthening granule of tortoise plastron and astragalus root
02/21/2007CN1301095C 'Yinchai' drop pills for treating cold, fever and cough and preparation method
02/20/2007US7179922 Chemical compounds
02/20/2007US7179910 3-(4-amidopyrrol-2-ylmethlidene)-2-indolinone derivatives as protein kinase inhibitors
02/20/2007US7179898 Human vanilloid receptor-like receptor
02/20/2007US7179835 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors
02/20/2007US7179823 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity
02/20/2007US7179822 Hetero biaryl derivatives as matrix metalloproteinase inhibitors
02/20/2007US7179821 Potassium/sodium channel blockers; for treatment of multiple sclerosis, spinal cord injury, traumatic brain injury, stroke, bladder irritation and dysfunction, neuropathic pain and chemokine-induced pain
02/20/2007US7179817 For therapy and prophylaxis of peripheral arterial disease such as arteriosclerosis obliterans, thromboangiitis obliterans, Buerger's disease or diabetic neuropathy, sepsis, angiitis, nephritis, pneumonia, stroke, myocardial infarction, edematous state, atherosclerosis, varicosity such as hemorrhoid
02/20/2007US7179810 Phthalazinone-piperidino-derivatives as PDE4 inhibitors
02/20/2007US7179804 Tachykinin receptor antagonists
02/20/2007US7179800 Cannabinoids
02/20/2007US7179647 For introducing DNA into organisms which produce large amounts of oils and, in particular, oils with a high content of unsaturated fatty acids
02/20/2007US7179627 Cyclooxygenase variants and methods of use
02/20/2007US7179491 Contacting marine oil with an effective amount of a silica under a vacuum;contacting the oil with an effective amount of a bleaching clay;separating the silica from the oil; and separating the clay from the oil
02/20/2007US7179460 Probiotic lactobacillus and bifidobacterium for treatment, prevention and/or reduction of allergenicity, gastrointestinal, cell proliferative and cholesterol disorders
02/20/2007CA2422374C Purine derivatives
02/20/2007CA2371174C Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors
02/20/2007CA2335520C Adenosine derivatives
02/20/2007CA2218872C Preparation and use of sulfated oligosaccharides
02/20/2007CA2218499C Chemokine binding protein and methods of use therefor
02/15/2007WO2007018469A1 Oxopyridyl quinoline amides as nk3 receptor modulators
02/15/2007WO2007018466A1 Alkylpyridyl quinolines as nk3 receptor modulators
02/15/2007WO2007018465A1 Amide alkyl pyridiyl quinolines as nk3 receptor modulators
02/15/2007WO2007018210A1 Adhesive patch less irritative to skin
02/15/2007WO2007018137A1 Multikinase inhibitor
02/15/2007WO2007017670A1 Bicyclo[2.2.]hept-7-ylamine derivatives and their uses
02/15/2007WO2007017643A1 3 , llB-CIS-DIHYDROTETRABENAZINE FOR THE TREATMENT OF A PROLIFERATIVE DISEASE OR AN INFLAMMATION
02/15/2007WO2007017512A1 Treatment of inflammatory diseases
02/15/2007WO2007017237A1 Imidazopyridine derivatives as cannabinoid receptor ligands
02/15/2007WO2007017125A1 Cb1 antagonists or inverse antagonists as therapeutical agents for the treatment of inflammation involving gene expression
02/15/2007WO2007017078A1 NEW PYRIDO[3',2':4,5]FURO[3,2-d]PYRIMIDINE DERIVATIVES
02/15/2007WO2007017058A1 Therapeutic combination comprising a nmda receptors blocker and a narcotic analgesic substance
02/15/2007WO2007016784A1 Novel substituted 1,2,3-tπazolylmethyl-benzothiophene or -indole and their use as leukotπene biosynthesis inhibitors
02/15/2007US20070037996 4-(N (S-glutathionylacetyl)amino)phenylarsenoxide (GSAO) and derivatives; antiinflammatory and antitumor agents; blood and autoimmune disorders; viral infections; anticoagulants
02/15/2007US20070037995 A Substantially Cell Membrane Impermeable Compound And Use Thereof
02/15/2007US20070037890 Cannabinoids
02/15/2007US20070037864 Intermediates for the preparation of lipoxin A4 analogs
02/15/2007US20070037835 Pharmaceutical composition comprising a cathepsin s inhibitor and an opioid
02/15/2007US20070037834 Bicyclic pyrimidine derivatives
02/15/2007US20070037830 2-Adamantyl derivatives as p2X7 receptor antagonists.
02/15/2007US20070037826 Indolylmaleimide derivatives
02/15/2007US20070037803 Benzimidazole derivatives
02/15/2007US20070037772 Pyrazolidinol compounds
02/15/2007US20070037765 gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening
02/15/2007US20070037749 Administering a N-terminus modified polypeptide derived from the fibrin alpha or beta chain; antiinflammatory agent, anticoagulants; transplant rejection; arteriosclerosis
02/15/2007US20070036877 Oral compositions and route of administration for the delivery of a thylakoid extract
02/15/2007US20070036854 Therapeutic applications of pro-apoptotic benzodiazepines
02/15/2007DE102005038141A1 Substituierte 8-(3-Aminopropyl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-on-Derivate Substituted 8- (3-aminopropyl) -1-phenyl-1,3,8-triaza-spiro [4.5] decan-4-one derivatives
02/15/2007DE102005037733A1 Adeninderivate Adenine derivatives
02/15/2007DE102005037653A1 Stabile, flüssige Formulierung von Paracetamol A stable liquid formulation of paracetamol
02/15/2007DE102005037499A1 Pyrazolderivate Pyrazole derivatives
02/15/2007DE102005034973A1 Salz von Dimethylaminomethyl-phenyl-cyclohexan und dessen kristalline Formen Salt of dimethylaminomethyl-phenyl-cyclohexane, and its crystalline forms
02/15/2007DE10141651B4 Transdermales Therapeutisches System (TTS) mit dem Wirkstoff Fentanyl und Verfahren zu seiner Herstellung Transdermal therapeutic system (TTS) with the active ingredient fentanyl and process for its preparation
02/15/2007CA2620952A1 3, 11b-cis-dihydrotetrabenazine for the treatment of a proliferative disease or an inflammation
02/15/2007CA2618586A1 Novel substituted 1,2,3-triazolylmethyl-benzothiophene or -indole and their use as leukotriene biosynthesis inhibitors
02/15/2007CA2618165A1 Imidazopyridine derivatives as cannabinoid receptor ligands
02/15/2007CA2618089A1 Bicyclo[2.2.]hept-7-ylamine derivatives and their uses
02/15/2007CA2616659A1 Therapeutic combination comprising a nmda receptors blocker and a narcotic analgesic substance
02/15/2007CA2616424A1 New pyrido[3',2':4,5]furo[3,2-d]pyrimidine derivatives
02/14/2007EP1752538A1 Human bikunin
02/14/2007EP1752162A1 Chronic articular inflammation-modulating composition based on collagen-polyvinylpyrrolidone
02/14/2007EP1752159A1 Medicinal composition and therapeutic method
02/14/2007EP1752149A1 CB1 Antagonists or inverse agonists as therapeutical agents for the treatment of inflammation involving gene expression
02/14/2007EP1752148A2 Substituted phenethylsulfones for the treatment of inflammatory, infectious, immunological or malignant disease
02/14/2007EP1751175A1 Interleukin-1 receptor antagonists, compositions, and methods of treatment
02/14/2007EP1751172A1 Novel 3-triazolyl-galactoside inhibitors of galectins
02/14/2007EP1751171A1 Novel galactoside inhibitors of galectins
02/14/2007EP1751151A1 Pyrazolo '3,4-b! pyridine compounds, and their use as phosphodiesterase type 4 (pde4) inhibitors
02/14/2007EP1751118A1 Pyrimidines for use as plk inhibitors
02/14/2007EP1750772A1 Phospholipase c gamma modulation and uses thereof for management of pain and nociception
02/14/2007EP1750746A1 Methods of using il-1 antagonists to treat autoinflammatory disease
02/14/2007EP1750745A1 Methods of inhibiting proinflammatory cytokine expression using ghrelin
02/14/2007EP1750735A1 Use of an aloysia/verbrena/lippia triphylla/citridora for treating chronic and /or inflammatory diseases
02/14/2007EP1750711A2 Treatment of neurogenerative and inflammatory conditions with morphinan
02/14/2007EP1750700A1 Liquid preparation for veterinary medicine, method for the production thereof, and use of the same